NDC 49884-723
Zileuton
Zileuton
Zileuton is a Oral Tablet, Multilayer, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Zileuton.
| Product ID | 49884-723_83a9c9a6-a8a5-4005-b18d-20ab56ef50f3 |
| NDC | 49884-723 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Zileuton |
| Generic Name | Zileuton |
| Dosage Form | Tablet, Multilayer, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-01-09 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA212670 |
| Labeler Name | Par Pharmaceutical, Inc. |
| Substance Name | ZILEUTON |
| Active Ingredient Strength | 600 mg/1 |
| Pharm Classes | 5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE],5-Lipoxygenase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |